Jun Nakayama

Scopus Author ID Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Venues

Genes to cells : devoted to molecular & cellular mechanisms

International journal of molecular sciences

Cancer research communications

Cancer discovery

Japan Society for the Promotion of Science

Waseda University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Japan Society for the Promotion of Science

Japan

Research Fellow

Waseda University

Japan

Assistant Professor :: Life Science and Medical Bioscience

Waseda University

Japan

Research Associate :: Life Science and Medical Bioscience

Education History

Waseda University

Japan

PHD :: Life Science and Medical Bioscience

Publications

Takahiko Murayama, Navin R Mahadevan, Catherine B Meador, Elena V Ivanova, Yuqiao Pan, Erik H Knelson, Tetsuo Tani, Jun Nakayama, Xueying Ma, Tran C Thai, Yin Pun Hung, Jong Wook Kim, Hideo Watanabe, Kathy Q Cai, Aaron N Hata, Cloud P Paweletz, David A Barbie, Israel Cañadas
Targeting TREX1 induces innate immune response in drug-resistant Small Cell Lung Cancer. Cancer research communications (2024)
Takahiko Murayama, Jun Nakayama, Xinpei Jiang, Kenichi Miyata, Alexander D Morris, Kathy Q Cai, Rahul M Prasad, Xueying Ma, Andrey Efimov, Neel Belani, Emily R Gerstein, Yin Fei Tan, Yan Zhou, Jong Wook Kim, Reo Maruyama, Kerry S Campbell, Lu Chen, Yibin Yang, Siddharth Balachandran, Israel Cañadas
Targeting DHX9 triggers tumor-intrinsic interferon response and replication stress in Small Cell Lung Cancer. Cancer discovery (2024)
Takahiko Murayama, Jun Nakayama, Xinpei Jiang, Kenichi Miyata, Alexander D Morris, Kathy Q Cai, Rahul M Prasad, Xueying Ma, Andrey Efimov, Neel Belani, Emily R Gerstein, Yin Fei Tan, Yan Zhou, Jong Wook Kim, Reo Maruyama, Kerry S Campbell, Lu Chen, Yibin Yang, Siddharth Balachandran, Israel Cañadas
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer. Cancer discovery 14 (3) (2024)
Kazushi Azuma, Mai Sakamoto, Shota Katayama, Atsuka Matsui, Kazuya Nakamichi, Naoki Goshima, Shinya Watanabe, Jun Nakayama, Kentaro Semba
HOXB7 induces STAT3-mediated transformation and lung metastasis in immortalized mammary gland NMuMG cells. Genes to cells : devoted to molecular & cellular mechanisms (2023)
Jun Nakayama, Yusuke Yamamoto
Cancer-prone Phenotypes and Gene Expression Heterogeneity at Single-cell Resolution in Cigarette-smoking Lungs. Cancer research communications (2023)
Yuxuan Han, Shota Katayama, Mitsuru Futakuchi, Kazuya Nakamichi, Yutaro Wakabayashi, Mai Sakamoto, Jun Nakayama, Kentaro Semba
Targeting c-Jun is a potential therapy for luminal breast cancer bone metastasis. Molecular cancer research : MCR (2023)
Kazushi Azuma, Mai Sakamoto, Shota Katayama, Atsuka Matsui, Kazuya Nakamichi, Naoki Goshima, Shinya Watanabe, Jun Nakayama, Kentaro Semba
HOXB7 induces STAT3-mediated transformation and lung metastasis in immortalized mammary gland NMuMG cells. Genes to cells : devoted to molecular & cellular mechanisms (2023)
Kazuya Nakamichi, Yusuke Yamamoto, Kentaro Semba, Jun Nakayama
Metastatic potentials classified with hypoxia-inducible factor 1 downstream genes in pan-cancer cell lines. Genes to cells : devoted to molecular & cellular mechanisms 29 (2) (2023)
Akira Yokoi, Kosuke Yoshida, Hirotaka Koga, Masami Kitagawa, Yukari Nagao, Mikiko Iida, Shota Kawaguchi, Min Zhang, Jun Nakayama, Yusuke Yamamoto, Yoshinobu Baba, Hiroaki Kajiyama, Takao Yasui
Spatial exosome analysis using cellulose nanofiber sheets reveals the location heterogeneity of extracellular vesicles. Nature communications 14 (1) (2023)
Kazuya Nakamichi, Yusuke Yamamoto, Kentaro Semba, Jun Nakayama
Metastatic potentials classified with hypoxia-inducible factor 1 downstream genes in pan-cancer cell lines. Genes to cells : devoted to molecular & cellular mechanisms (2023)
Kazuya Nakamichi, Yusuke Yamamoto, Kentaro Semba, Jun Nakayama
Metastatic potentials classified with hypoxia-inducible factor 1 downstream genes in pan-cancer cell lines. Genes to cells : devoted to molecular & cellular mechanisms 29 (2) (2023)
Kosuke Yoshida, Akira Yokoi, Tomofumi Yamamoto, Yusuke Hayashi, Jun Nakayama, Tsuyoshi Yokoi, Hiroshi Yoshida, Tomoyasu Kato, Hiroaki Kajiyama, Yusuke Yamamoto
Aberrant Activation of Cell-Cycle-Related Kinases and the Potential Therapeutic Impact of PLK1 or CHEK1 Inhibition in Uterine Leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Momoko Tokura, Jun Nakayama, Marta Prieto-Vila, Sho Shiino, Masayuki Yoshida, Tomofumi Yamamoto, Naoaki Watanabe, Shin Takayama, Yutaka Suzuki, Koji Okamoto, Takahiro Ochiya, Takashi Kohno, Yasushi Yatabe, Akihiko Suto, Yusuke Yamamoto
Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ. Cancer research 82 (18) (2022)
Jun Nakayama, Hiroko Matsunaga, Koji Arikawa, Takuya Yoda, Masahito Hosokawa, Haruko Takeyama, Yusuke Yamamoto, Kentaro Semba
Identification of two cancer stem cell-like populations in triple-negative breast cancer xenografts. Disease models & mechanisms 15 (6) (2022)
Yuxuan Han, Kazushi Azuma, Shinya Watanabe, Kentaro Semba, Jun Nakayama
Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models. Clinical & experimental metastasis 39 (3) (2022)
Shiyu Ayukawa, Nagisa Kamoshita, Jun Nakayama, Ryohei Teramoto, Novalia Pishesha, Kenji Ohba, Nanami Sato, Kei Kozawa, Hikari Abe, Kentaro Semba, Nobuhito Goda, Yasuyuki Fujita, Takeshi Maruyama
Epithelial cells remove precancerous cells by cell competition via MHC class I-LILRB3 interaction. Nature immunology 22 (11) (2021)
Kanako Nishiyama, Masashi Maekawa, Tomoya Nakagita, Jun Nakayama, Takeshi Kiyoi, Mami Chosei, Akari Murakami, Yoshiaki Kamei, Hiroyuki Takeda, Yasutsugu Takada, Shigeki Higashiyama
CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP. Life science alliance 4 (9) (2021)
Satomi Yogosawa, Makiko Ohkido, Takuro Horii, Yasumasa Okazaki, Jun Nakayama, Saishu Yoshida, Shinya Toyokuni, Izuho Hatada, Mitsuru Morimoto, Kiyotsugu Yoshida
Mice lacking DYRK2 exhibit congenital malformations with lung hypoplasia and altered Foxf1 expression gradient. Communications biology 4 (1) (2021)
Jun Nakayama, Yuxuan Han, Yuka Kuroiwa, Kazushi Azuma, Yusuke Yamamoto, Kentaro Semba
The In Vivo Selection Method in Breast Cancer Metastasis. International journal of molecular sciences 22 (4) (2021)
Ryohei Saito-Moriya, Jun Nakayama, Genta Kamiya, Nobuo Kitada, Rika Obata, Shojiro A Maki, Hiroshi Aoyama
How to Select Firefly Luciferin Analogues for In Vivo Imaging. International journal of molecular sciences 22 (4) (2021)
Yuxuan Han, Jun Nakayama, Yusuke Hayashi, Seongmoon Jeong, Mitsuru Futakuchi, Emi Ito, Shinya Watanabe, Kentaro Semba
Establishment and characterization of highly osteolytic luminal breast cancer cell lines by intracaudal arterial injection. Genes to cells : devoted to molecular & cellular mechanisms 25 (2) (2020)
Jun Nakayama, Ryohei Saito, Yusuke Hayashi, Nobuo Kitada, Shota Tamaki, Yuxuan Han, Kentaro Semba, Shojiro A Maki
High Sensitivity In Vivo Imaging of Cancer Metastasis Using a Near-Infrared Luciferin Analogue seMpai. International journal of molecular sciences 21 (21) (2020)
Yuka Kuroiwa, Jun Nakayama, Chihiro Adachi, Takafumi Inoue, Shinya Watanabe, Kentaro Semba
Proliferative Classification of Intracranially Injected HER2-positive Breast Cancer Cell Lines. Cancers 12 (7) (2020)

Jun Nakayama.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jun Nakayama